Salubris Biotherapeutics Inc   Report issue

For profit Phase 1
Founded: Gaithersburg MD United States (2016)

Organization Overview

First Clinical Trial
2020
NCT04210375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Salubris Biotherapeutics Inc